Apotex Inc - Company Profile
Powered by 
All the sales intelligence you need on Apotex Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Apotex Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Apotex Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Apotex Inc (Apotex) develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, and disposable plastics for medical use. The company produces approximately 460 generic drugs in approximately 4,000 dosages and formats. Apotex markets drugs in more than 115 countries through its distributors and subsidiaries in Latin America, Europe, the Middle East, Australia, and Asia. It produces up to 25 billion doses per year.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D efforts focus on generic and innovative pharmaceuticals, with a particular emphasis on developing treatments for neurodegenerative diseases by modifying iron metabolism. It conducts research to create generic, biosimilar, and innovative medications. Apotex has several generic and biotechnology products in progress. The company has invested over US$2 billion over the past ten years to develop innovative product solutions in various categories.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer